Efficacy of Korean Red Ginseng in the Treatment of Alopecia Areata

    October 2012 in “Journal of Ginseng Research
    Ga Na Oh, Sang Wook Son
    Image of study
    TLDR Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.
    The study, conducted 11 years ago, assessed the effectiveness and safety of Korean Red Ginseng (KRG) in treating Alopecia Areata (AA) by comparing two patient groups: one receiving corticosteroid intra-lesional injection (ILI) alone (Group 2) and the other receiving ILI combined with KRG (Group 1). With 50 patients evenly split between the groups, results after 12 weeks showed no significant differences in hair density and thickness between the groups. However, an expert panel's assessment of global photographs indicated a significant improvement in hair regrowth for the KRG-treated group (Group 1) over the ILI-only group (Group 2), with average scores of 3.6 versus 3.1 (p<0.05). No side effects were noted in the KRG group. The study concluded that KRG could be beneficial as an adjunctive treatment for AA.
    View this study on koreascience.or.kr →

    Cited in this study

    Related

      research Alopecia Areata

        May 2011 in “Harper's Textbook of Pediatric Dermatology”
      Alopecia areata was described as a non-scarring, multifocal hair growth disorder characterized by patchy hair loss that could occur on any hair-bearing site of the body. It could range from a few circular bald areas to complete baldness of the head or entire body. The condition was believed to be an autoimmune disease with a genetic basis and environmental triggers. Treatments often involved immunosuppressing or immunomodulating agents, which had variable effectiveness, but there were no cures or ways to prevent relapses. Common treatments discussed included corticosteroids, topical sensitizers, and minoxidil.

      research Interventions for alopecia areata

      2 citations ,   February 2009 in “Journal of Evidence-Based Medicine”
      The review examined 17 randomized controlled trials with 540 participants to evaluate treatments for alopecia areata, including topical and oral steroids, topical ciclosporin, photodynamic therapy, and topical minoxidil. The trials were small and poorly reported, showing no significant long-term hair growth benefits over placebo. The review highlighted the need for larger, well-designed studies with control groups, focusing on safe, sustainable treatments and including patient satisfaction and quality of life measures. It also suggested testing supportive therapies like wigs against pharmaceutical interventions.